DURECT Corporation (DRRX) Financials

DRRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 12.5 million 8.5 million
March 31, 2025 14.4 million 9.0 million
Dec. 31, 2024 18.3 million 9.2 million
Sept. 30, 2024 24.1 million 22.8 million

DRRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -1.8 million 397000
March 31, 2025 -3.6 million 452000
Dec. 31, 2024 -5.5 million 594000
Sept. 30, 2024 -3.1 million 458000

DRRX Net Income

No data available :(

DRRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 6.5 million 1.3 million 652000
March 31, 2025 8.3 million 893000 2.0 million
Dec. 31, 2024 11.8 million 1.1 million 2.2 million
Sept. 30, 2024 10.4 million 2.0 million 3.3 million

DRRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 31.2 million
March 31, 2025 31.0 million
Dec. 31, 2024 31.4 million
Sept. 30, 2024 31.0 million

DRRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - 428000 2.1 million -
March 31, 2025 7000 1.9 million 2.6 million -
Dec. 31, 2024 - 1.9 million 1.2 million -
Sept. 30, 2024 - 2.2 million 3.2 million -

DRRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 447000 7000
March 31, 2025 321000 69000
Dec. 31, 2024 453000 22000
Sept. 30, 2024 1.9 million 513000

DRRX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DRRX

Price: $1.91

52 week price:
0.48
2.64

Earnings Per Share: -0.43 USD

P/E Ratio: -4.44

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 37400

Ebitda: 6.8 million

Market Capitalization: 59.3 million

Links: